NEW YORK – Quest Diagnostics has sold its minority share of lab services firm Q2 Solutions to Iqvia for $760 million in an all-cash transaction, the companies said on Thursday.
Iqvia and Quest established Q2 solutions, originally known as Quintiles Research, as a joint venture in 2015, with Iqvia owning 60 percent and Quest owning 40 percent.